Meningococcal Vaccine Market to Receive Impetus from Introduction of a Series of Broad-range, Low-co
Search jobs Meningococcal Vaccine Market to Receive Impetus from Introduction of a Series of Broad-range, Low-cost Vaccines Meningococcal meningitis is a rare but potentially devastating bacterial infection that targets the brain. Despite growing advances in medical care, the disease can kill the host within a relatively lesser timespan. One in 10 meningococcal meningitis patients die from the disease, and ~15% of the survivors suffer from deadly complications, which typically include brain damage, deafness, or/and amputation. Partnerships between the private sector a...
Source: pharmiweb.com
